PROSTATIC NEOPLASMS
Clinical trials for PROSTATIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smart drug deliver a toxic payload to prostate cancer cells?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called JNJ-98768111 in people with advanced prostate cancer that has spread to other parts of the body. The drug is designed to seek out and attach to a protein called KLK2 on prostate cancer cells, delivering a toxic agent d…
Matched conditions: PROSTATIC NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug (GV20-0251) combined with an immunotherapy (anti-PD-1) in people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. About 227 adults with various cancers, including lung, breast, and colorectal, will participa…
Matched conditions: PROSTATIC NEOPLASMS
Phase: PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a simple WhatsApp message save lives? chile tests new screening nudge
Knowledge-focused Not yet recruitingThis study will send different types of WhatsApp messages to 235,000 people in Chile who are due for cancer or chronic disease screenings. Researchers want to see if the way a message is worded (basic, risk-focused, or peace-of-mind) and whether it mentions one test or both tests…
Matched conditions: PROSTATIC NEOPLASMS
Phase: NA • Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC